Skip to main content
Erschienen in: World Journal of Surgery 11/2010

01.11.2010

Survival Benefit of Hepatopancreatoduodenectomy for Cholangiocarcinoma in Comparison to Hepatectomy or Pancreatoduodenectomy

verfasst von: Yuji Kaneoka, Akihiro Yamaguchi, Masatoshi Isogai, Takashi Kumada

Erschienen in: World Journal of Surgery | Ausgabe 11/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Perihilar and distal cholangiocarcinoma remain difficult to treat, and long-term survival is poor. We conducted a retrospective study of patients with cholangiocarcinoma to examine whether hepatopancreatoduodenectomy, in comparison to standard surgeries, provides a survival benefit.

Methods

Subjects were 75 patients with perihilar or distal cholangiocarcinoma who, between April 1997 and May 2007, underwent hepatectomy with bile duct resection (Hx, n = 29), pancreatoduodenectomy (PD, n = 32), or hepatopancreatoduodenectomy (HPD, n = 14) at our hospital. We compared surgical outcomes and survival between groups and identified factors negatively influencing survival.

Results

Morbidity and in-hospital mortality did not differ significantly between groups (Hx group, 34% and 10%, respectively; PD group, 44% and 3%; and HPD, 57% and 0%). The overall median survival time was 39 months, and overall 5-year survival (including in-hospital mortality) was 42%. Respective group values were as follows: Hx, 24 months and 31%; PD, 51 months and 49%, and HPD, 63 months and 50%. Although the number of patients was small, survival in the HPD was not influenced by the type of invasion whether widespread intramural invasion (n = 8), superficial spread (n = 4), or hepatoduodenal ligament invasion (n = 2). Multivariate analysis (Cox proportional hazards model) showed only perineural invasion (p = .007) and decreased curability (R1/2 resection) (p = .017) to be independent risk factors influencing survival.

Conclusions

In cases of perihilar or distal cholangiocarcinoma, aggressive surgery must be aimed at overcoming perineural invasion. Our findings indicate that HPD improves survival of patients undergoing surgery for widespread cholangiocarcinoma in comparison to standard surgeries.
Literatur
1.
Zurück zum Zitat Burke EC, Jarnagin WR, Hochwald SN et al (1998) Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 228:385–394CrossRefPubMed Burke EC, Jarnagin WR, Hochwald SN et al (1998) Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 228:385–394CrossRefPubMed
2.
Zurück zum Zitat Jarnagin WR, Fong Y, DeMatteo RP et al (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234:507–519CrossRefPubMed Jarnagin WR, Fong Y, DeMatteo RP et al (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234:507–519CrossRefPubMed
3.
Zurück zum Zitat Kondo S, Hirano S, Ambo Y et al (2004) Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg 240:95–101CrossRefPubMed Kondo S, Hirano S, Ambo Y et al (2004) Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg 240:95–101CrossRefPubMed
4.
Zurück zum Zitat Ikeyama T, Nagino M, Oda K et al (2007) Surgical approach to Bismuth type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases. Ann Surg 246:1052–1057CrossRefPubMed Ikeyama T, Nagino M, Oda K et al (2007) Surgical approach to Bismuth type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases. Ann Surg 246:1052–1057CrossRefPubMed
5.
Zurück zum Zitat Yeo CJ, Sohn TA, Cameron JL et al (1998) Periampullary adnocarcinoma: analysis of 5-year survivors. Ann Surg 227:821–831CrossRefPubMed Yeo CJ, Sohn TA, Cameron JL et al (1998) Periampullary adnocarcinoma: analysis of 5-year survivors. Ann Surg 227:821–831CrossRefPubMed
6.
Zurück zum Zitat Sakamoto Y, Kosuge T, Shimada K et al (2005) Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radical margins. Surgery 137:396–402CrossRefPubMed Sakamoto Y, Kosuge T, Shimada K et al (2005) Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radical margins. Surgery 137:396–402CrossRefPubMed
7.
Zurück zum Zitat Takasaki K, Kobayashi S, Muto H et al (1980) Our experience (5 cases) of extended right lobectomy combined with pancreatoduodenectomy for the carcinoma of the gallbladder. Tan To Sui 7:923–932 (in Japanese) Takasaki K, Kobayashi S, Muto H et al (1980) Our experience (5 cases) of extended right lobectomy combined with pancreatoduodenectomy for the carcinoma of the gallbladder. Tan To Sui 7:923–932 (in Japanese)
8.
Zurück zum Zitat Nimura Y, Hayakawa N, Kamiya J et al (1991) Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract. Hepatogastroenterology 38:170–175PubMed Nimura Y, Hayakawa N, Kamiya J et al (1991) Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract. Hepatogastroenterology 38:170–175PubMed
9.
Zurück zum Zitat Tsukada K, Yoshida K, Aono T et al (1994) Major hepatectomy and pancreatoduodenectomy for advanced carcinoma of the biliary tract. Br J Surg 81:108–110CrossRefPubMed Tsukada K, Yoshida K, Aono T et al (1994) Major hepatectomy and pancreatoduodenectomy for advanced carcinoma of the biliary tract. Br J Surg 81:108–110CrossRefPubMed
10.
Zurück zum Zitat Hanyu F, Nakamura M, Yoshikawa T (1998) Hepato-ligamento-pancreatoduodenectomy (in Japanese). Gekachiryo (Surg Ther) 59:12–21 Hanyu F, Nakamura M, Yoshikawa T (1998) Hepato-ligamento-pancreatoduodenectomy (in Japanese). Gekachiryo (Surg Ther) 59:12–21
11.
Zurück zum Zitat Nagino M, Nimura Y, Kamiya J et al (1996) Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology 200:559–563PubMed Nagino M, Nimura Y, Kamiya J et al (1996) Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology 200:559–563PubMed
12.
Zurück zum Zitat Sobin HL, Wittekind C (2002) TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York Sobin HL, Wittekind C (2002) TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York
13.
Zurück zum Zitat Ebata T, Kamiya J, Nishio H et al (2009) The concept of perihilar cholangiocarcinoma is valid. Br J Surg 96:926–934CrossRefPubMed Ebata T, Kamiya J, Nishio H et al (2009) The concept of perihilar cholangiocarcinoma is valid. Br J Surg 96:926–934CrossRefPubMed
14.
Zurück zum Zitat Bassi C, Dervenis C, Butturini G et al (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8–13CrossRefPubMed Bassi C, Dervenis C, Butturini G et al (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8–13CrossRefPubMed
15.
Zurück zum Zitat Wente MN, Bassi C, Dervenis C et al (2007) Delayed gastric empting (DGE) after pancreatic surgery: a suggested definition by the international study group of pancreatic surgery (ISGPS). Surgery 142:761–768CrossRefPubMed Wente MN, Bassi C, Dervenis C et al (2007) Delayed gastric empting (DGE) after pancreatic surgery: a suggested definition by the international study group of pancreatic surgery (ISGPS). Surgery 142:761–768CrossRefPubMed
16.
Zurück zum Zitat Japanese Society of Biliary Surgery (2003) General rules for surgical and pathological studies on cancer of the biliary tract, 5th edn. Kanehara Shuppan, Tokyo, pp 60–61 (in Japanese) Japanese Society of Biliary Surgery (2003) General rules for surgical and pathological studies on cancer of the biliary tract, 5th edn. Kanehara Shuppan, Tokyo, pp 60–61 (in Japanese)
17.
Zurück zum Zitat Kaneoka Y, Yamaguchi A, Isogai M et al (2003) Hepatoduodenal ligament invasion by gallbladder carcinoma: histologic patterns and surgical recommendation. World J Surg 27:260–265CrossRefPubMed Kaneoka Y, Yamaguchi A, Isogai M et al (2003) Hepatoduodenal ligament invasion by gallbladder carcinoma: histologic patterns and surgical recommendation. World J Surg 27:260–265CrossRefPubMed
18.
Zurück zum Zitat Kaneoka Y, Yamaguchi A, Isogai M (2007) Hepatopancreatoduodenectomy: its suitability for bile duct cancer versus gallbladder cancer. J Hepatobiliary Pancreat Surg 14:142–148CrossRefPubMed Kaneoka Y, Yamaguchi A, Isogai M (2007) Hepatopancreatoduodenectomy: its suitability for bile duct cancer versus gallbladder cancer. J Hepatobiliary Pancreat Surg 14:142–148CrossRefPubMed
19.
Zurück zum Zitat Miyagawa S, Makuuchi M, Kawasaki S et al (1996) Outcome of major hepatectomy with pancreatoduodenectomy for advanced biliary malignancies. World J Surg 20:77–80CrossRefPubMed Miyagawa S, Makuuchi M, Kawasaki S et al (1996) Outcome of major hepatectomy with pancreatoduodenectomy for advanced biliary malignancies. World J Surg 20:77–80CrossRefPubMed
20.
Zurück zum Zitat Ebata T, Nagino M, Nishio H et al (2007) Right hepatopancreatoduodenectomy: improvements over 23 years to attain acceptability. J Hepatobiliary Pancreat Surg 14:131–135CrossRefPubMed Ebata T, Nagino M, Nishio H et al (2007) Right hepatopancreatoduodenectomy: improvements over 23 years to attain acceptability. J Hepatobiliary Pancreat Surg 14:131–135CrossRefPubMed
21.
Zurück zum Zitat Ishihara S, Miyakawa S, Takada T et al (2007) Status of surgical treatment of biliary tract cancer. Dig Surg 24:131–136CrossRefPubMed Ishihara S, Miyakawa S, Takada T et al (2007) Status of surgical treatment of biliary tract cancer. Dig Surg 24:131–136CrossRefPubMed
22.
Zurück zum Zitat Kawasaki S, Makuuchi M, Miyagawa S et al (1994) Radical operation after portal embolization for tumor of hilar bile duct. J Am Coll Surg 178:480–486PubMed Kawasaki S, Makuuchi M, Miyagawa S et al (1994) Radical operation after portal embolization for tumor of hilar bile duct. J Am Coll Surg 178:480–486PubMed
23.
Zurück zum Zitat Kawasaki S, Imamura H, Kobayashi A et al (2003) Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 238:84–92CrossRefPubMed Kawasaki S, Imamura H, Kobayashi A et al (2003) Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 238:84–92CrossRefPubMed
24.
Zurück zum Zitat Seyama Y, Kubota K, Sano K et al (2003) Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 238:73–83CrossRefPubMed Seyama Y, Kubota K, Sano K et al (2003) Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 238:73–83CrossRefPubMed
25.
Zurück zum Zitat Nagino M, Kamiya J, Nishio H et al (2006) Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 243:364–372CrossRefPubMed Nagino M, Kamiya J, Nishio H et al (2006) Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 243:364–372CrossRefPubMed
26.
Zurück zum Zitat Makuuchi M, Thai BL, Takayasu K et al (1990) Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107:521–527PubMed Makuuchi M, Thai BL, Takayasu K et al (1990) Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107:521–527PubMed
27.
Zurück zum Zitat Nagino M, Nimura Y, Kamiya J et al (1995) Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology 21:434–439PubMed Nagino M, Nimura Y, Kamiya J et al (1995) Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology 21:434–439PubMed
28.
Zurück zum Zitat Seyama Y, Makuuchi M (2007) Current surgical treatment for bile duct cancer. World J Gastroenterol 13:1505–1515PubMed Seyama Y, Makuuchi M (2007) Current surgical treatment for bile duct cancer. World J Gastroenterol 13:1505–1515PubMed
29.
Zurück zum Zitat Yoshimi F, Asato Y, Amemiya R et al (2001) Comparison between pancreatoduodenectomy and hepatopancreatoduodenectomy for bile duct cancer. Hepatogastroenterology 48:994–998PubMed Yoshimi F, Asato Y, Amemiya R et al (2001) Comparison between pancreatoduodenectomy and hepatopancreatoduodenectomy for bile duct cancer. Hepatogastroenterology 48:994–998PubMed
30.
Zurück zum Zitat Miyagawa S, Makuuchi M, Kawasaki S et al (1994) Second-stage pancreatojejunostomy following pancreatoduodenectomy in high-risk patients. Am J Surg 168:66–68CrossRefPubMed Miyagawa S, Makuuchi M, Kawasaki S et al (1994) Second-stage pancreatojejunostomy following pancreatoduodenectomy in high-risk patients. Am J Surg 168:66–68CrossRefPubMed
31.
Zurück zum Zitat Neuhaus P, Jonas S, Bechsein WO et al (1999) Extended resections for hilar cholangiocarcinoma. Ann Surg 230:808–819CrossRefPubMed Neuhaus P, Jonas S, Bechsein WO et al (1999) Extended resections for hilar cholangiocarcinoma. Ann Surg 230:808–819CrossRefPubMed
32.
Zurück zum Zitat Ebata T, Nagino M, Kamiya J et al (2003) Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg 238:720–727CrossRefPubMed Ebata T, Nagino M, Kamiya J et al (2003) Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg 238:720–727CrossRefPubMed
33.
Zurück zum Zitat Nimura Y, Kamiya J, Kondo S et al (2000) Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg 7:155–162CrossRefPubMed Nimura Y, Kamiya J, Kondo S et al (2000) Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg 7:155–162CrossRefPubMed
34.
Zurück zum Zitat Sakamoto Y, Shimada K, Nara S et al (2010) Surgical management of infrahilar/suprapancreatic cholangiocarcinoma: an analysis of the surgical procedures, surgical margins, and survivals of 77 patients. J Gastrointest Surg 14:335–343CrossRefPubMed Sakamoto Y, Shimada K, Nara S et al (2010) Surgical management of infrahilar/suprapancreatic cholangiocarcinoma: an analysis of the surgical procedures, surgical margins, and survivals of 77 patients. J Gastrointest Surg 14:335–343CrossRefPubMed
35.
Zurück zum Zitat Miyazaki M, Kato A, Ito H et al (2007) Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery 141:581–588CrossRefPubMed Miyazaki M, Kato A, Ito H et al (2007) Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery 141:581–588CrossRefPubMed
36.
Zurück zum Zitat Nakamura S, Suzuki S, Serizawa A et al (1996) Hepatopancreatoduodenectomy for superficially spreading bile duct carcinoma: a report of two 5 year survivals. Hepatogastroenterology 43:138–142PubMed Nakamura S, Suzuki S, Serizawa A et al (1996) Hepatopancreatoduodenectomy for superficially spreading bile duct carcinoma: a report of two 5 year survivals. Hepatogastroenterology 43:138–142PubMed
37.
Zurück zum Zitat Miwa S, Kobayashi A, Akahane Y et al (2007) Is major hepatectomy with pancreatoduodenectomy justified for advanced biliary malignancy? J Hepatobiliary Pancreat Surg 14:136–141CrossRefPubMed Miwa S, Kobayashi A, Akahane Y et al (2007) Is major hepatectomy with pancreatoduodenectomy justified for advanced biliary malignancy? J Hepatobiliary Pancreat Surg 14:136–141CrossRefPubMed
38.
Zurück zum Zitat Kaneoka Y, Yamaguchi A, Isogai M et al (2003) Longer than 3-year survival following hepato-ligamento-pancreatoduodenectomy for hilar cholangiocarcinoma with vascular involvement: report of a case. Surg Today 33:772–776CrossRefPubMed Kaneoka Y, Yamaguchi A, Isogai M et al (2003) Longer than 3-year survival following hepato-ligamento-pancreatoduodenectomy for hilar cholangiocarcinoma with vascular involvement: report of a case. Surg Today 33:772–776CrossRefPubMed
39.
Zurück zum Zitat Klempnauer J, Ridder GJ, Werner M et al (1997) What constitutes long term survival after surgery for hilar cholangiocarcinoma? Cancer 79:26–34CrossRefPubMed Klempnauer J, Ridder GJ, Werner M et al (1997) What constitutes long term survival after surgery for hilar cholangiocarcinoma? Cancer 79:26–34CrossRefPubMed
40.
Zurück zum Zitat DeOliveira ML, Cunningham SC, Cameron JL et al (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245:755–762CrossRefPubMed DeOliveira ML, Cunningham SC, Cameron JL et al (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245:755–762CrossRefPubMed
41.
Zurück zum Zitat Bhuiya MR, Nimura Y, Kamiya J et al (1992) Clinicopathological studies on perineural invasion of bile duct carcinoma. Ann Surg 215:344–349CrossRefPubMed Bhuiya MR, Nimura Y, Kamiya J et al (1992) Clinicopathological studies on perineural invasion of bile duct carcinoma. Ann Surg 215:344–349CrossRefPubMed
42.
Zurück zum Zitat Ogura Y, Takahashi K, Tabata M et al (1994) Clinicopathological study on carcinoma of the extrahepatic bile duct with special focus on cancer invasion on the surgical margins. World J Surg 18:778–784CrossRefPubMed Ogura Y, Takahashi K, Tabata M et al (1994) Clinicopathological study on carcinoma of the extrahepatic bile duct with special focus on cancer invasion on the surgical margins. World J Surg 18:778–784CrossRefPubMed
Metadaten
Titel
Survival Benefit of Hepatopancreatoduodenectomy for Cholangiocarcinoma in Comparison to Hepatectomy or Pancreatoduodenectomy
verfasst von
Yuji Kaneoka
Akihiro Yamaguchi
Masatoshi Isogai
Takashi Kumada
Publikationsdatum
01.11.2010
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 11/2010
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-010-0702-2

Weitere Artikel der Ausgabe 11/2010

World Journal of Surgery 11/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.